Collectively, our research revealed that NS5A inhibits the phosphorylation of AMPK at Thr172, and augments the expression of SREBP-1c and its targeted genes, resulting in hepatic steatosis. The gene discussed is PRKAA2; the disease is Hepatic steatosis.